International Clinical Trial: Efficacy of Topical 0.05% Cyclosporine or Ocular Surface Disease After Vitrectomy Surgery

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012351) titled 'Efficacy of Topical 0.05% Cyclosporine or Ocular Surface Disease After Vitrectomy Surgery' on July 29.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Single, Blinding Target : Investigator, Outcome Accessor, Allocation : RCT

Primary Sponsor: Seoul National University Hospital

Condition:

Diseases of the eye and adnexa

Intervention: Drug : Participants will be randomly assigned in a 1:1 ratio to either the control group or the intervention group. The control group will instill one drop of 0.15% sodium hyaluronate artificial tears (New H...